Hereditary Renal/Urinary Tract Cancers Panel Test code: 01361 • 10–21 days turnaround time. 39 genes

Hereditary Prostate Cancer Panel                            39 genes

This panel analyzes genes associated with an adult-onset hereditary predisposition to prostate cancer. Because prostate cancer susceptibility can involve multiple genes and genetic pathways, the underlying cause may not always be determined through clinical characteristics or family history alone.

The clinical features of hereditary prostate cancer conditions may overlap, making broad panel testing useful for efficiently evaluating multiple potential genes based on a single clinical indication. Identifying a hereditary genetic variant may provide important information for cancer risk assessment, screening, surveillance, and medical management.

Genetic testing may provide valuable information by helping to:

• Confirm or clarify a clinical diagnosis

• Identify an inherited predisposition to prostate cancer

• Assess hereditary cancer risk

• Guide appropriate cancer screening and surveillance

• Facilitate earlier detection of cancer or related symptoms

• Help inform disease prognosis and progression

• Support personalized medical management and risk-reduction strategies

• Inform family planning and genetic counseling

• Identify potentially affected relatives who may benefit from genetic testing

• Support consideration for relevant clinical trials

Some genes included in this panel may also be associated with additional medical conditions unrelated to hereditary prostate cancer. These conditions are not included among the disorders specifically evaluated by this test.

Important Testing Information:
This panel is specifically designed to identify heritable germline genetic variants. It is not intended to detect somatic mutations in tumor tissue and should not be used as a substitute for tumor-based somatic testing.